Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 208 - XBI Rally, ASH Highlights & '24 Picks
	Category:		Science & Medicine
	Duration:		00:24:37
	Publish Date:		2023-12-19 01:00:00
	Description:		Signals from the Fed that rate cuts are on the way rallied biotech indexes last week, but is the uptick more than a blip? On the latest BioCentury This Week podcast, BioCentury’s editors discuss how interest rate cuts could spur a risk-on rotation back into the sector by generalist investors, the possibility of biotech outperformance in 2024, and what it will take for the IPO window to open. They also assess progress demonstrated by companies’ with next-generation gene editors at this year’s American Society of Hematology (ASH) meeting, as well as BioCentury’s analysis of new targets at the conference. The editors also offer their picks for the highlights (and lowlights) of 2023 and predictions for what’s in store in the New Year. Music for the 24th Bio€quity Europe teaser produced by: Thomas de Paula Eby, Andreas Unge, Epidemic Sound via Getty Images
	Total Play:		0